Assignee
SEMA4 OPCO INC
US·0 granted patents·2 pending applications·0 citations·filing 2022–2022
Top patents by PatentIndex Score
2 records- 0155US2024175087A1Methods and systems for predicting cancer homologous recombination pathway deficiency, and determining treatment responseSEMA4 OPCO INC·Filed 2022·Application pending·0 cites
- 0248US2023074363A1Methods and systems for machine learning-powered identification of cancer diagnoses and diagnosis dates from electronic health recordsSEMA4 OPCO INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SEMA4 OPCO INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →